Mathew Blackman
Stock Analyst at Stifel
(3.43)
# 974
Out of 5,124 analysts
61
Total ratings
60.47%
Success rate
15.35%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $6.72 | +4.17% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $21.98 | +41.04% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $310.91 | +2.28% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $13.68 | +82.75% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $30.47 | -17.95% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $284.24 | +3.08% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $87.31 | +7.66% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $15.16 | +58.31% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $2.06 | +45.63% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $66.37 | +50.67% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $21.04 | -23.95% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.96 | +10.44% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $6.72
Upside: +4.17%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $21.98
Upside: +41.04%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $310.91
Upside: +2.28%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $13.68
Upside: +82.75%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $30.47
Upside: -17.95%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $284.24
Upside: +3.08%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $87.31
Upside: +7.66%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $15.16
Upside: +58.31%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $2.06
Upside: +45.63%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $66.37
Upside: +50.67%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $21.04
Upside: -23.95%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.96
Upside: +10.44%